Answers are grounded in this paper and cite their sources.
We report a 17-year-old male with a novel mutation leading to congenital sideroblastic anemia (CSA). The patient presented with isolated and severe non-regenerative anemia (hemoglobin: 37 g/L, normal range 135–168 g/L) and a hypercellular bone marrow with increased erythropoiesis and ring sideroblasts (RS). After an extensive work-up, molecular investigation identified a germline variant of the erythroid-specific delta-aminolevulinic acid synthase 2 ( ALAS2 ) gene with a thymine-to-cytosine substitution at nucleotide 905 (NM_000032.5:c.905T > C), resulting in a p.Phe302Ser amino acid change. While ALAS2 is the most frequently affected gene in CSA, this variant of the ALAS2 gene has not yet been documented in the literature. Vitamin B 6 supplementation led to rapid improvement and transfusion independence, as is reported in approximately 50% of cases of CSA. Shortly after, the patient was also diagnosed with ulcerative colitis (UC), which may have aggravated the anemia. Despite successful treatment of the UC, the patient has microcytosis and requires continuous vitamin B 6 supplementation. In this case report, we discuss the diagnostic approach and its challenges in male young adults with anemia. CSA can indeed remain asymptomatic until adulthood. Its correct diagnosis is essential as it may allow transfusions to be avoided it potentially allows avoiding transfusions and their significant morbidity with a specific and simple treatment.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: